Independent website, not affiliated with any government.

Official Gazette of the Federation (DOF) Mexico · Official source

Decision

Mexico sets new rules for using residual plasma to make blood medicines

Summary by AI · translated from Spanish

New rules for Mexican blood banks regulate the use of residual plasma for the industrial production of blood derivatives.

Public and private blood banks in Mexico must now follow new guidelines for disposing of residual plasma to be used in the industrial production of blood derivatives. These rules apply to any blood bank wishing to send plasma for industrialization and to companies producing therapeutic, diagnostic, or preventive blood products.
To participate, blood banks must have a valid sanitary license specifying plasma shipment, a current sanitary responsibility notice, and a favorable technical opinion from the National Blood Transfusion Center. Agreements or contracts for plasma disposal must be signed and cannot involve direct monetary exchange for the plasma.
What we do not know: the specific technical requirements for the monthly quality control reports and the exact digital platform to be used once the National Blood Transfusion Center implements technological improvements.

Headlines and summaries are written by AI for Outer News (RS Elite Pro s.r.o.) from the official text and are not reviewed by a person. They are not the official text and can contain mistakes: before you rely on one, read the original.

Original title: Acuerdo por el que se emiten los Lineamientos que deberán observar los bancos de sangre para la disposición del Plasma Residual con fines de industrialización para la producción de hemoderivados.

Read the official decision dof.gob.mx

Source: Official Gazette of the Federation (DOF)

Get the app

Official decisions from around the world, in a few calm sentences, on your phone.